Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
about
Complications and challenges associated with polycystic ovary syndrome: current perspectivesPregnancy complications in women with polycystic ovary syndromeOvarian hyperstimulation syndrome: pathophysiology, staging, prediction and preventionCellular and molecular mechanisms of metformin: an overviewModulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patientsThe menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective studyVoluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS).Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthoodPhase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitusEffects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndromeCo-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI.Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metforminMetformin and other biguanides in oncology: advancing the research agenda.Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal modelsFirst-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndromeAnti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females.Approach to the girl with early onset of pubic hair.Gerosuppressant metformin: less is morePolycystic ovary syndrome in the pediatric populationEvaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatmentPolycystic ovary syndrome: chemical pharmacotherapy.Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome.Study of lipid profile in adult women with acne.Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep.Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemiaMedical management of metabolic dysfunction in PCOS.Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study.Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
P2860
Q26799566-66E53B9C-0F02-4025-A65B-9FA66D86C01BQ26822402-61C32D3A-A61C-4A9F-B85F-34F11F9915A0Q26827593-CD218E73-63DD-4F43-85EB-1EDA247A9600Q27013561-947B5437-2D49-4B63-A508-7A91ED8B0C24Q28235398-95D4173D-8EFE-4CCF-8A52-9E29D97D89FEQ28248914-996A38C0-3279-477E-8708-EF7E287736D4Q30355011-8B9AE601-2833-43F9-A4C9-9FC349636022Q30428511-2D13B028-483E-42D2-BB91-26B4ED0D420FQ31115487-7B0D96D6-A950-4469-B07A-C0B15FE0EB69Q33569169-7F0A33B8-12CC-40FF-80FE-ECA06406BC72Q33588919-727CAE52-A5CC-420B-934E-37877E404E08Q33602108-99A25A25-233F-4A97-8003-770ECB713F83Q33675285-5DB95EB5-FB13-4491-A009-F94A2258DE99Q33759065-31E99136-BB64-4DF2-8C3E-6D4A558662EEQ33937237-38EE0F6F-C343-4C6A-9051-D1D295ACE8AAQ34031584-0AE71670-AE97-4203-B6CE-1A4612A61423Q34196114-3CCABA62-00B4-4123-B553-EA92F656AD50Q34244204-8AD94E51-DE16-41B9-B917-4FA061962411Q34421386-48E20382-40C0-40D1-8138-ABD43E9F780AQ34546109-0B30F32B-47AA-4463-8E96-A84D04C45D13Q34708805-45550D53-1E25-4E57-91D2-6D9ADE0F8C41Q34769332-FBB0D9F5-35C1-4233-A680-1AC6F20F6137Q35001879-3E0DDBDA-2F10-4C84-93A0-84FF187CBF85Q35052060-BD41A882-B189-4F25-9E13-B93749795D00Q35075035-8C105FD8-3728-46C4-811A-18A448DD56AAQ35099918-079460DD-420E-4A90-8EDD-1EB329A2B35BQ35639510-A010E416-3478-4746-9B63-4E5CEDE5CC7FQ35662997-E4A3A6BA-D2D2-4971-AE27-F47CBCC43962Q35841226-9733819F-F7D1-4BFF-A283-23433D5286EDQ35981867-6C5DA12B-4816-4B5C-ADC7-B6194F04F436Q35986009-01DD2796-1982-4EC1-8A5B-944958064EC5Q36072462-39D9E154-73AF-4BE5-95D6-224C28F23799Q36132055-9FBFBE77-7F96-4432-B492-160C0CF1D4AAQ36182504-81D71C48-CE24-4D44-9B81-080241A6FA5CQ36265522-7D55E7C7-D369-4E01-AE24-C9D36F2B0766Q36301761-5297E38E-32CE-4584-9904-7BADCE9AB2A2Q36328060-39D2774A-C214-4C25-A0D3-435FB31AFAF2Q36360786-28368751-3E39-4C39-8530-5C3513CF72D6Q36741706-641B1396-59D1-469C-947C-7F112071F3A5Q37067105-1F5488CA-8472-4EFB-9A35-CAEC813A1435
P2860
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence-based and potential b ...... drome: a comprehensive review.
@en
Evidence-based and potential b ...... drome: a comprehensive review.
@nl
type
label
Evidence-based and potential b ...... drome: a comprehensive review.
@en
Evidence-based and potential b ...... drome: a comprehensive review.
@nl
prefLabel
Evidence-based and potential b ...... drome: a comprehensive review.
@en
Evidence-based and potential b ...... drome: a comprehensive review.
@nl
P2093
P356
P1433
P1476
Evidence-based and potential b ...... drome: a comprehensive review.
@en
P2093
Angela Falbo
Francesco Orio
Fulvio Zullo
Stefano Palomba
P356
10.1210/ER.2008-0030
P577
2008-12-04T00:00:00Z